Question 1

What is IMDX stock?

Accepted Answer

IMDX is the ticker symbol for Insight Molecular Diagnostics Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks IMDX with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Question 2

Is IMDX a good stock to buy?

Accepted Answer

13F Pro's AI ranking engine scores IMDX at 23.7/100, ranked #2,681 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for IMDX is available at https://13fpro.ai/company/IMDX. Not investment advice — review the underlying SEC filings before making any trade.

Question 3

Where does 13F Pro source IMDX data?

Accepted Answer

All Insight Molecular Diagnostics Inc. fundamentals and ownership data come directly from SEC EDGAR. Insight Molecular Diagnostics Inc. files with the SEC under CIK 1642380. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$4.1M	$-50.2M	—
FY 2024	10-K	$1.9M	$-60.7M	—
FY 2023	10-K	$1.5M	$-27.8M	—
FY 2022	10-K	$958.0K	$-72.9M	—
FY 2021	10-K	$2.2M	$-64.1M	—
FY 2020	10-K	$1.2M	$-29.9M	—

Insight Molecular Diagnostics Inc. IMDX

Top Institutional Holders

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

IMDX key financials by period

IMDX insiders

About Insight Molecular Diagnostics Inc. (IMDX): stock profile, AI score and financials